{"_id": "34202541|None", "id": "34202541", "infons": {}, "passages": [{"infons": {"journal": "Life (Basel). 2021 Jun 24;11(7):607. doi: 10.3390/life11070607.", "year": "2021", "article-id_pmc": "PMC8305580", "type": "title", "authors": "Hyun S, Shin D"}, "offset": 0, "text": "Chemical-Mediated Targeted Protein Degradation in Neurodegenerative Diseases.", "sentences": [], "annotations": [{"id": "1", "infons": {"identifier": "MESH:D019636", "type": "Disease", "valid": true, "normalized": ["D019636"], "database": "ncbi_mesh", "normalized_id": "D019636", "biotype": "disease", "name": "Neurodegenerative Diseases", "accession": "@DISEASE_Neurodegenerative_Diseases"}, "text": "Neurodegenerative Diseases", "locations": [{"offset": 50, "length": 26}]}], "relations": []}, {"infons": {"type": "abstract"}, "offset": 78, "text": "Neurodegenerative diseases, including Alzheimer's disease, Huntington's disease, and Parkinson's disease, are a class of diseases that lead to dysfunction of cognition and mobility. Aggregates of misfolded proteins such as beta-amyloid, tau, alpha-synuclein, and polyglutamates are known to be among the main causes of neurodegenerative diseases; however, they are considered to be some of the most challenging drug targets because they cannot be modulated by conventional small-molecule agents. Recently, the degradation of target proteins by small molecules has emerged as a new therapeutic modality and has garnered the interest of the researchers in the pharmaceutical industry. Bifunctional molecules that recruit target proteins to a cellular protein degradation machinery, such as the ubiquitin-proteasome system and autophagy-lysosome pathway, have been designed. The representative targeted protein degradation technologies include molecular glues, proteolysis-targeting chimeras, hydrophobic tagging, autophagy-targeting chimeras, and autophagosome-tethering compounds. Although these modalities have been shown to degrade many disease-related proteins, such technologies are expected to be potentially important for neurogenerative diseases caused by protein aggregation. Herein, we review the recent progress in chemical-mediated targeted protein degradation toward the discovery of drugs for neurogenerative diseases.", "sentences": [], "annotations": [{"id": "12", "infons": {"identifier": "MESH:D019636", "type": "Disease", "valid": true, "normalized": ["D019636"], "database": "ncbi_mesh", "normalized_id": "D019636", "biotype": "disease", "name": "Neurodegenerative Diseases", "accession": "@DISEASE_Neurodegenerative_Diseases"}, "text": "Neurodegenerative diseases", "locations": [{"offset": 78, "length": 26}]}, {"id": "13", "infons": {"identifier": "MESH:D000544", "type": "Disease", "valid": true, "normalized": ["D000544"], "database": "ncbi_mesh", "normalized_id": "D000544", "biotype": "disease", "name": "Alzheimer Disease", "accession": "@DISEASE_Alzheimer_Disease"}, "text": "Alzheimer's disease", "locations": [{"offset": 116, "length": 19}]}, {"id": "14", "infons": {"identifier": "MESH:D006816", "type": "Disease", "valid": true, "normalized": ["D006816"], "database": "ncbi_mesh", "normalized_id": "D006816", "biotype": "disease", "name": "Huntington Disease", "accession": "@DISEASE_Huntington_Disease"}, "text": "Huntington's disease", "locations": [{"offset": 137, "length": 20}]}, {"id": "15", "infons": {"identifier": "MESH:D010300", "type": "Disease", "valid": true, "normalized": ["D010300"], "database": "ncbi_mesh", "normalized_id": "D010300", "biotype": "disease", "name": "Parkinson Disease", "accession": "@DISEASE_Parkinson_Disease"}, "text": "Parkinson's disease", "locations": [{"offset": 163, "length": 19}]}, {"id": "16", "infons": {"identifier": "MESH:D003072", "type": "Disease", "valid": true, "normalized": ["D003072"], "database": "ncbi_mesh", "normalized_id": "D003072", "biotype": "disease", "name": "Cognition Disorders", "accession": "@DISEASE_Cognition_Disorders"}, "text": "dysfunction of cognition and mobility", "locations": [{"offset": 221, "length": 37}]}, {"id": "17", "infons": {"identifier": "4137", "type": "Gene", "ncbi_homologene": "74962", "valid": true, "normalized": [4137], "database": "ncbi_gene", "normalized_id": 4137, "biotype": "gene", "name": "MAPT", "accession": "@GENE_MAPT"}, "text": "tau", "locations": [{"offset": 315, "length": 3}]}, {"id": "18", "infons": {"identifier": "6622", "type": "Gene", "ncbi_homologene": "293", "valid": true, "normalized": [6622], "database": "ncbi_gene", "normalized_id": 6622, "biotype": "gene", "name": "SNCA", "accession": "@GENE_SNCA"}, "text": "alpha-synuclein", "locations": [{"offset": 320, "length": 15}]}, {"id": "19", "infons": {"identifier": "MESH:D019636", "type": "Disease", "valid": true, "normalized": ["D019636"], "database": "ncbi_mesh", "normalized_id": "D019636", "biotype": "disease", "name": "Neurodegenerative Diseases", "accession": "@DISEASE_Neurodegenerative_Diseases"}, "text": "neurodegenerative diseases", "locations": [{"offset": 397, "length": 26}]}, {"id": "20", "infons": {"identifier": "MESH:D001750", "type": "Disease", "valid": true, "normalized": ["D001750"], "database": "ncbi_mesh", "normalized_id": "D001750", "biotype": "disease", "name": "Urinary Bladder Neurogenic", "accession": "@DISEASE_Urinary_Bladder_Neurogenic"}, "text": "neurogenerative diseases", "locations": [{"offset": 1305, "length": 24}]}, {"id": "21", "infons": {"identifier": "MESH:D001750", "type": "Disease", "valid": true, "normalized": ["D001750"], "database": "ncbi_mesh", "normalized_id": "D001750", "biotype": "disease", "name": "Urinary Bladder Neurogenic", "accession": "@DISEASE_Urinary_Bladder_Neurogenic"}, "text": "neurogenerative diseases", "locations": [{"offset": 1483, "length": 24}]}], "relations": []}], "relations": [{"id": "R1", "infons": {"score": "0.9779", "role1": {"identifier": "MESH:D019636", "type": "Disease", "valid": true, "normalized": ["D019636"], "database": "ncbi_mesh", "normalized_id": "D019636", "biotype": "disease", "name": "Neurodegenerative Diseases", "accession": "@DISEASE_Neurodegenerative_Diseases"}, "role2": {"identifier": "6622", "type": "Gene", "valid": true, "normalized": [6622], "database": "ncbi_gene", "normalized_id": 6622, "biotype": "gene", "name": "SNCA", "accession": "@GENE_SNCA"}, "type": "Association"}, "nodes": [{"refid": "0", "role": "8,7"}]}, {"id": "R2", "infons": {"score": "0.6156", "role1": {"identifier": "MESH:D019636", "type": "Disease", "valid": true, "normalized": ["D019636"], "database": "ncbi_mesh", "normalized_id": "D019636", "biotype": "disease", "name": "Neurodegenerative Diseases", "accession": "@DISEASE_Neurodegenerative_Diseases"}, "role2": {"identifier": "4137", "type": "Gene", "valid": true, "normalized": [4137], "database": "ncbi_gene", "normalized_id": 4137, "biotype": "gene", "name": "MAPT", "accession": "@GENE_MAPT"}, "type": "Association"}, "nodes": [{"refid": "1", "role": "8,6"}]}], "pmid": 34202541, "pmcid": null, "meta": {}, "date": "2021-06-24T00:00:00Z", "journal": "Life (Basel)", "authors": ["Hyun S", "Shin D"], "relations_display": [{"name": "associate|@DISEASE_Neurodegenerative_Diseases|@GENE_SNCA"}, {"name": "associate|@DISEASE_Neurodegenerative_Diseases|@GENE_MAPT"}]}
